Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition– PCI - CHAMPION PCI

Description:

The goal of this trial was to compare treatment with intravenous cangrelor compared with clopidogrel 600 mg among patients undergoing percutaneous coronary intervention (PCI).